DIN 02539845 — OMVOH 100 MG
OMVOH is a solution of Mirikizumab marketed by ELI LILLY CANADA INC. The full Mirikizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02539845
- Brand name
- OMVOH
- Active ingredient
- Mirikizumab
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ELI LILLY CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-23 (IL-23) p19 antagonist (biologic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mirikizumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02539853 | OMVOH | 100 MG | SOLUTION | ELI LILLY CANADA INC | MARKETED |
| 02539861 | OMVOH | 20 MG | SOLUTION | ELI LILLY CANADA INC | MARKETED |
| 02559218 | OMVOH | 200 MG | SOLUTION | ELI LILLY CANADA INC | MARKETED |
| 02559234 | OMVOH | 200 MG; 100 MG | KIT | ELI LILLY CANADA INC | MARKETED |
| 02559242 | OMVOH | 200 MG; 100 MG | KIT | ELI LILLY CANADA INC | MARKETED |
| 02559226 | OMVOH | 200 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED |